Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalTrial registry record – peer review not applicable

Interventional Study of StableEyes in Human Subjects

A study involving 138 human participants aimed to evaluate the effect of an intervention called StableEyes. The primary outcome was to measure Composite VOR gain (cVOR gain). However, no results have been posted, and planned enrollment and endpoints were not reported as findings.

Most relevant to
—
This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
No results yet
Outcome
Not reported

Why it matters

Understanding the efficacy of interventions like StableEyes is crucial for developing potential treatments for conditions impacting vestibular function, but current data is lacking.

What this does not prove

The study lacks posted results, making it impossible to assess outcomes or scientific validity; planned enrollment and endpoints do not provide evidence of effectiveness or safety.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Interventional
Participants / samples
138 · estimated
Randomised
Yes
Controlled
Yes
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
Not reported
Evidence reviewed
Trial registry record
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
Not reported
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (14)
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years to 89 Years; sex All
speciesParticipants: people; ages from 18 Years to 89 Years; sex All
sample sizeEnrollment: 138 participants (estimated)
sample size basisEnrollment: 138 participants (estimated)
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
randomizedAllocation: Randomized
controlledArm types: Experimental; Experimental; No intervention
primary endpointPrimary endpoints: Composite VOR gain (cVOR gain)
interventionInterventions: StableEyes
follow upFollow-up: Weeks 0,1,2,3,4,5,6, 7, and 18; Weeks 0,1, 4, 7, and 18; Weeks 1, 4, 7, and 18

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.